Technological watch

MD&M West Reveals 2022 Educational MedTech Conference Content: 3D Printing and Biomaterials to Robotics and Digital Health

ANAHEIM, Calif.--(BUSINESS WIRE)--, , in addition to the third annual MedtechWomen, Chemical Angel Network (CAN), and the Keynote: The Science of Predictive Healthcare and the Role of Nano-polymers & Medical Plastics.
SPE's MiniTec (Tuesday, April 12, 8:00 a.m.)
Predictive medicine has its roots in early warning systems and diagnostic early detection. Prognostic devices are a new genre of diagnostic devices that not only detect and diagnose diseases but predict and, in many ways, prevent the onset of diseases. Imagine a point-of-care device that can detect BNP, a cardiac marker that is produced by the heart in very minute quantities before the advent of arrhythmia. Then the doctor can prevent the disease by changing the patient's lifestyle, diet and exercise. The first forays in predictive medicine more than a decade ago has spawned a new generation of predictive methods and prognostic medical devices. From ctDNA liquid biopsy techniques (that detect cancer at the very early stages and can pinpoint the location of the tumor) and metabolomics biosensors (that prevent stroke through a combination of bio-electronics, data science and AI) to tumor-hunting nanobots and CRISPR-based scissors (that cut out defective genes before the onset of the disease), these methodologies are making expert-level preventive care accessible to the millions of people at-risk. Even in the Covid-19 pandemic, medical-grade plastics have made a significant impact – the most exciting development is the use of medical nano polymers formed into carriers that protect the mRNA-based vaccine from being destroyed by the body’s own defenses before they can do their job! The engine that is driving all of this is Medical Plastics.

Speaker from mFluiDx.

Chemical Angel Network
(Wednesday, April 13, 8:30 a.m. – 5:00 p.m.)
The three-legged stool of medical device innovation requires great technical capability, of course, but also a deep understanding of the related medicine (anatomy, pathology, procedural knowledge, outcomes, standard of care, clinical trials) and the business of innovation (patents, fundraising, management, strategy). These elements will be highlighted as the story of TAVR development is told; the twists and turns of technology challenges, patents, difficult fundraising, difficult regulators, and tough strategic choices. Join leading industry innovator Stanton Rowe as he discusses:

  • How to think about customer needs when customers do not know what they need
  • Innovation roadblocks - some are technical, some are market-related
  • If you know the customer you serve, decisions about strategy are so much easier
Speaker from NXT Biomedical

  • Twitter
  • About Informa Markets – Engineering:

    Informa Markets' Engineering portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit

    Publication date: 28/02/2022

    Business Wire


    This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.